Aurora Cannabis Inc Total Assets
Aurora Cannabis Inc total assets. Based on the latest financial reports, Aurora Cannabis Inc (ACB) holds total assets worth CA$620.88 Million CAD (≈ $449.13 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ACB market cap for the company's overall valuation and market capitalisation.
Total Assets of Aurora Cannabis Inc (2007–2026)
Total assets of Aurora Cannabis Inc from 2007 to 2026. This chart illustrates how Aurora Cannabis Inc's total assets have evolved over time, based on quarterly financial data. See latest Aurora Cannabis Inc stock price today for real-time trading data and today's change.
Aurora Cannabis Inc - Asset Composition Analysis
Aurora Cannabis Inc Total Assets Breakdown (March 2026)
Aurora Cannabis Inc total assets breakdown as of March 2026. Aurora Cannabis Inc's total assets of CA$620.88 Million consist of 66.1% current assets and 33.9% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 18.7% |
| Accounts Receivable | CA$44.58 Million | 7.4% |
| Inventory | CA$175.07 Million | 29.1% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$31.44 Million | 5.2% |
| Goodwill | CA$26.65 Million | 4.4% |
Asset Composition Trend (2007–2026)
This chart illustrates how Aurora Cannabis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Aurora Cannabis Inc current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aurora Cannabis Inc's current assets represent 66.1% of total assets in 2026, a decrease from 96.4% in 2007.
- Cash Position: Cash and equivalents constituted 18.7% of total assets in 2026, down from 96.2% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 29.1% of total assets.
Aurora Cannabis Inc Competitors by Total Assets
Key competitors of Aurora Cannabis Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Aurora Cannabis Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.36 | 2.97 | 5.42 |
| Quick Ratio | 2.80 | 1.51 | 4.13 |
| Cash Ratio | 0.00 | 0.89 | 2.76 |
| Working Capital | CA$320.02 Million | CA$308.42 Million | CA$532.61 Million |
Aurora Cannabis Inc - Advanced Valuation Insights
This section examines the relationship between Aurora Cannabis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.62 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | -29.5% |
| Total Assets | CA$601.09 Million |
| Market Capitalization | $259.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aurora Cannabis Inc's assets below their book value (0.43x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Aurora Cannabis Inc's assets decreased by 29.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aurora Cannabis Inc (2007–2026)
The table below shows the annual total assets of Aurora Cannabis Inc from 2007 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | CA$601.09 Million ≈ $434.82 Million |
-29.50% |
| 2025-03-31 | CA$852.67 Million ≈ $616.81 Million |
+1.67% |
| 2024-03-31 | CA$838.67 Million ≈ $606.68 Million |
-9.46% |
| 2023-03-31 | CA$926.32 Million ≈ $670.09 Million |
-14.57% |
| 2022-03-31 | CA$1.08 Billion ≈ $784.41 Million |
-58.37% |
| 2021-03-31 | CA$2.60 Billion ≈ $1.88 Billion |
-6.43% |
| 2020-03-31 | CA$2.78 Billion ≈ $2.01 Billion |
-49.41% |
| 2019-03-31 | CA$5.50 Billion ≈ $3.98 Billion |
+188.00% |
| 2018-03-31 | CA$1.91 Billion ≈ $1.38 Billion |
+492.14% |
| 2017-03-31 | CA$322.68 Million ≈ $233.42 Million |
+1654.02% |
| 2016-03-31 | CA$18.40 Million ≈ $13.31 Million |
+36.00% |
| 2015-03-31 | CA$13.53 Million ≈ $9.78 Million |
+616.70% |
| 2014-03-31 | CA$1.89 Million ≈ $1.37 Million |
+162.66% |
| 2013-03-31 | CA$718.54K ≈ $519.78K |
-35.91% |
| 2012-03-31 | CA$1.12 Million ≈ $811.07K |
-19.22% |
| 2011-03-31 | CA$1.39 Million ≈ $1.00 Million |
-19.74% |
| 2010-03-31 | CA$1.73 Million ≈ $1.25 Million |
+6.27% |
| 2009-03-31 | CA$1.63 Million ≈ $1.18 Million |
-3.81% |
| 2008-03-31 | CA$1.69 Million ≈ $1.22 Million |
+280.13% |
| 2007-03-31 | CA$445.06K ≈ $321.95K |
-- |
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more